Quarterly Statement Of Cash Flows

Japan Medical Dynamic Marketing, INC. - Filing #7295643

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
641,895,000 JPY
539,064,000 JPY
Depreciation
835,655,000 JPY
788,215,000 JPY
Increase (decrease) in allowance for doubtful accounts
1,643,000 JPY
-80,000 JPY
Interest and dividend income
-89,000 JPY
-44,000 JPY
Foreign exchange losses (gains)
-135,936,000 JPY
35,193,000 JPY
Decrease (increase) in trade receivables
599,859,000 JPY
109,166,000 JPY
Decrease (increase) in inventories
-875,816,000 JPY
-255,937,000 JPY
Increase (decrease) in trade payables
-358,304,000 JPY
91,580,000 JPY
Other, net
-114,420,000 JPY
-83,055,000 JPY
Subtotal
426,674,000 JPY
1,444,655,000 JPY
Interest and dividends received
89,000 JPY
44,000 JPY
Interest paid
-16,560,000 JPY
-9,461,000 JPY
Income taxes paid
-323,735,000 JPY
-538,968,000 JPY
Net cash provided by (used in) operating activities
85,523,000 JPY
719,244,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-772,024,000 JPY
-790,072,000 JPY
Other, net
597,000 JPY
296,000 JPY
Net cash provided by (used in) investing activities
-774,726,000 JPY
-796,034,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-249,374,000 JPY
-291,753,000 JPY
Purchase of treasury shares
-55,000 JPY
-61,000 JPY
Dividends paid
-371,044,000 JPY
-343,775,000 JPY
Net cash provided by (used in) financing activities
653,014,000 JPY
-642,655,000 JPY
Effect of exchange rate change on cash and cash equivalents
-25,294,000 JPY
58,968,000 JPY
Net increase (decrease) in cash and cash equivalents
-61,483,000 JPY
-660,477,000 JPY
Cash and cash equivalents
2,260,068,000 JPY
2,321,552,000 JPY
2,144,451,000 JPY
2,804,928,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.